Effects of L- and D-arginine on the basal tone of human diseased coronary arteries and their responses to substance P

Heart

Volumn 81, Issue 5, 1999, Pages 505-511

  Tousoulis, D ^a   Tentolouris, C ^a   Crake, T ^b   Katsimaglis, G ^a   Stefanadis, C ^a   Toutouzas, P ^a   Davies, G J ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Coronary artery disease; Endothelium; L arginine; Nitric oxide; Vasomotor tone

Indexed keywords

ARGININE; DEXTRO ARGININE; NITRIC OXIDE; SUBSTANCE P;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD VESSEL TONE; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DRUG EFFECT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0032951366     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.81.5.505     Document Type: Article

References (45)

1. 1 Vanhoutte PM. The endothelium. Modulator of vascular smooth muscle tone. N Engl J Med 1988;319:512-13.
2. 2 Bassenge E, Busse R. Endothelial modulation of coronary tone. Prog Cardiovasc Dis 1988;30:349-60.
3. 3 Luecher TF, Richard V, Tschudi M, et al. Endothelial control of vascular tone in large and small coronary arteries. J Am Coll Cardiol 1990;15:512-27.
4. 4 Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-6.
5. 5 Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
6. 6 Rees DD, Palmer RMJ, Hodson HF, et al. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 1989; 96:418-24.
7. 7 Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology pathology and pharmacology. Pharmacol Rev 1991;43:109-42.
8. 8 Panza JA, Quyyumi AA, Bruch JE, et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
9. 9 Casino PR, Kilcoyne CM, Quyyumi AA, et al. Investigation of decreased availability of nitric oxide precursor as a mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients. J Am Coll Cardiol 1994;23:844-50.
10. 10 Zeiher AM, Drexler H, Wollschlager H, et al. Modulation of coronary vasomotor tone in humans. Progressive dysfunction with different early stages of coronary atherosclerosis. Circulation 1991;83:391-401.
11. 11 Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;81:491-7.
12. 12 Tousoulis D, Davies GJ, Lefroy D, et al. Variable coronary vasomotor responses to acetylcholine in patients with normal coronary arteriograms: evidence for localised endothelial dysfunction. Heart 1996;65:261-6.
13. 13 Hirooka Y, Egashira K, Imaizumi T, et al. Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans. J Am Coll Cardiol 1994;24:948-55.
14. 14 Creager MA, Gallagher SM, Girerd XJ, et al. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992;90:1248-53.
15. 15 Imaizumi T, Hirooka Y, Masaki H, et al. Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension 1992;20:511-17.
16. 16 Jeremy RW, McCarron H, Sullivan D. Effects of dietary L-arginine on atherosclerosis and endothelium-dependent vasodilation in the hypercholesterolemic rabbit: response according to treatment duration, anatomic site, and sex. Circulation 1996;94:498-506.
17. 17 Drexler H, Zeiher AM, Meinzer K, et al. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet 1991; 338:1546-50.
18. 18 Crossman DC, Larkin SW, Dashwood MR, et al. Responses of atherosclerotic coronary arteries in vivo to the endothelium-dependent vasodilator substance P. Circulation 1991;84:2001-10.
19. 19 Mugge A, Heublein B, Kuhn M, et al. Impaired coronary-dilator response to substance P and impaired flow-dependent dilator responses in heart transplant patients with graft vasculopathy. J Am Coll Cardiol 1993;21:163-70.
20. 20 Reiber JHC, Serruys PW, Koouman C, et al. Assessment of short-, medium, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 1985;71:280-8.
21. 21 Tousoulis D, Davies G, McFadden E, et al. Coronary vasomotor effects of setotonin in patients with angina. Relationship to coronary stenosis morphology. Circulation 1993;88:1518-26.
22. 22 Saner HE, Gobel FL, Salomonowitz E, et al. The disease-free wall in coronary atherosclerosis: its relation to degree of obstruction. J Am Coll Cardiol 1985;6:1096-9.
23. 23 Brown G, Bolson E, Dodge H. Dynamic mechanisms in human coronary stenosis. Circulation 1984;70:917-22.
24. 24 Brown G, Bolson E, Petersen R, et al. The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response. Circulation 1981;64: 1089-97.
25. 25 Kaski JC, Tousoulis D, Haider WA, et al. Reactivity of eccentric and concentric stenoses in chronic stable angina. J Am Coll Cardiol 1991;17:627-33.
26. 26 Tousoulis D, Kaski JC, Bogaty P, et al. Reactivity of proximal and distal angiographically normal and stenotic coronary segments in chronic stable angina pectoris. Am J Cardiol. 1991;67:1195-200.
27. 27 Rafflenbeul W, Urthaler F, Russel R, et al. Dilatation of coronary artery stenoses after isosorbide dinitrate in man. Br Heart J 1980;43:546-9.
28. 28 Feldman R, Pepine C, Conti R. Magnitude of dilatation of large and small coronary arteries by nitroglycerin. Circulation 1981;64:324-33.
29. 29 Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-51.
30. 30 Clancy RM, Leszczynska P, Piziak J, et al. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on NADPH oxidase. J Clin Invest 1992;90:1116-21.
31. 31 Buttery LDK, Springall DR, Chester AH, et al. Inducible NO synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 1996;75:77-85.
32. 32 Hogg N, Darley-Usman VM, Wilson MT, et al. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J 1992;281:419-24.
33. 33 Cooke JP, Andon NA, Girerd XJ, et al. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation 1991;83:1057-62.
34. 34 Egashira K, Hirooka Y, Kuga T, et al. Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograms. Circulation 1996;94:130-4.
35. 35 Drexler H, Fischell TA, Pinto F, et al. Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology. Circulation 1994; 89:1615-23.
36. 36 Quyyumi A, Dakak N, Diodati J, et al. Effect of L-arginine on human coronary endothelial-dependent and physiologic vasodilation. J Am Coll Cardiol 1997;30:1220-7.
37. 37 Weihe E, Reinecke M, Opherk D, et al. Peptidergic innervation (substance P) in the human heart. J Mol Cell Cardiol 1981;13:331-3.
38. 38 Kilpatrick EV, Cocks TM. Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery. Br J Pharmacol 1904;112:557-65.
39. 39 Crossman DC, Larkin SW, Fuller RW, et al. Substance P dilates epicardial coronary arteries and increases coronary blood flow in humans. Circulation 1989;80:475-84.
40. 40 Panza JA, Casino PR, Badar DM, et al. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 1993;87:1475-81.
41. 41 Tanner FC, Noll G, Boulanger CM, et al. Oxidized low-density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation 1991;83: 2012-20.
42. 42 Girerd XJ, Hirsch AT, Cooke JP, et al. L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res 1990;67:1301-8.
43. 43 Tousoulis D, Tentolouris C, Crake T, et al. Basal and flow-mediated nitric oxide production by atheromatous coronary arteries. J Am Coll Cardiol 1997;29:1256-62.
44. 44 Aji W, Ravalli S, Szabolcs M, et al. L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice. Circulation 1997;95:430-7.
45. 45 Cooke JP, Singer AH, Tsao PS, et al. Anti-atherogenic effects of L-arginine in hypercholesterolemic rabbit. J Clin Invest 1992;90:1168-72.